JEFFREY GOLDBERG

Profile

First Name

: JEFFREY

Middle Name

:

Last Name

: GOLDBERG

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER ENERGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-18 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2025-12-18 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2025-04-04 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-09-17 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-12-31 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-05-17 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-05-17 
D
TELECOMMUNICATIONS 
 
DECLINE TO DISCLOSE 
Equity 
2025-02-11 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-06 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-06 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-06 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-06 
D/A
OTHER INVESTMENT FUND 
 
 
Equity 
2024-01-16 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-28 
D
OTHER 
 
$1,000,001 - $5,000,000 
Equity 
2018-02-01 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-07-31